Torben Arnth Nielsen

Chief Executive Officer at

Arnth Advice ApS

66 year

44 connections

Finance

Health Technology

Health Services

Profile

Torben Arnth Nielsen is currently the Chairman at BI Biomedical Venture Annex Komplementar A, Director at Bioporto Diagnostics A, Managing Director & Director at Arnth Advice ApS, and Director at Wavepiston A. Previously, he served as the Chief Executive Officer at BI Asset Management Fondsmæglerselskab A, Chief Executive Officer at BankInvest AS from 2008 to 2012, Vice Chairman at Bioporto A from 2013 to 2021, Director at Nasdaq Copenhagen A, Director at Veterinary Diagnostics Institute, Inc., and Member-Executive Board at Sydbank A from 1998 to 2008.

Torben Arnth Nielsen active positions

Companies	Position	Start
BI Biomedical Venture Annex Komplementar A/S BI Biomedical Venture Annex Komplementar A/S Financial ConglomeratesFinance Provides financial services	Chairman	04/02/2011
Arnth Advice ApS	Chief Executive Officer	-
Wavepiston A/S Wavepiston A/S Electric UtilitiesUtilities Develops and delivers wave energy technology for power production and desalination	Director/Board Member	-
Bioporto Diagnostics A/S Bioporto Diagnostics A/S BiotechnologyHealth Technology Engages in research and experimental development on biotechnology	Director/Board Member	-

All active positions of Torben Arnth Nielsen

Former positions of Torben Arnth Nielsen

Companies	Position	End
BIOPORTO A/S	Director/Board Member	29/04/2021
BankInvest AS BankInvest AS Financial ConglomeratesFinance Provides investment services	Chief Executive Officer	01/01/2012
BI Asset Management Fondsmæglerselskab A/S BI Asset Management Fondsmæglerselskab A/S Investment ManagersFinance BIAM emphasizes long-term investments, bottom-up stock-picking approach and cash flow analysis. They base their investment process on fundamental research including company visits and extensive use of outsourced industrial expertise from non-financial analysts associated with the sectors in which they invest. The firm invests globally in listed equity, debt and alternative asset classes including private equity. BIAM favors companies with strong cash flow, growth potential within their sector and solid business models. They have specialist expertise in emerging market securities, both equity and fixed income, and invest in the Far East, Latin America and Eastern Europe.	President	08/09/2011
AL SYDBANK A/S	Corporate Officer/Principal	01/01/2008
Nasdaq Copenhagen A/S Nasdaq Copenhagen A/S Investment Banks/BrokersFinance Engages in financial market and trading services	Director/Board Member	-

See the detail of Torben Arnth Nielsen's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Torben Arnth Nielsen's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Nasdaq Copenhagen A/S Nasdaq Copenhagen A/S Investment Banks/BrokersFinance Engages in financial market and trading services	Finance
BI Asset Management Fondsmæglerselskab A/S BI Asset Management Fondsmæglerselskab A/S Investment ManagersFinance BIAM emphasizes long-term investments, bottom-up stock-picking approach and cash flow analysis. They base their investment process on fundamental research including company visits and extensive use of outsourced industrial expertise from non-financial analysts associated with the sectors in which they invest. The firm invests globally in listed equity, debt and alternative asset classes including private equity. BIAM favors companies with strong cash flow, growth potential within their sector and solid business models. They have specialist expertise in emerging market securities, both equity and fixed income, and invest in the Far East, Latin America and Eastern Europe.	Finance
Sydbank A/S Sydbank A/S Major BanksFinance Provides commercial banking and asset management services	Finance
Bioporto A/S Bioporto A/S Medical SpecialtiesHealth Technology Develops and markets human and animal neutrophil gelatinase-associated lipocalin antibodies kits	Health Technology
BI Biomedical Venture Annex Komplementar A/S BI Biomedical Venture Annex Komplementar A/S Financial ConglomeratesFinance Provides financial services	Finance
Bioporto Diagnostics A/S Bioporto Diagnostics A/S BiotechnologyHealth Technology Engages in research and experimental development on biotechnology	Health Technology
Veterinary Diagnostics Institute, Inc. Veterinary Diagnostics Institute, Inc. Medical/Nursing ServicesHealth Services Provides veterinary reference laboratory services and in-house diagnostic products	Health Services
Arnth Advice ApS
Wavepiston A/S Wavepiston A/S Electric UtilitiesUtilities Develops and delivers wave energy technology for power production and desalination	Utilities
BankInvest AS BankInvest AS Financial ConglomeratesFinance Provides investment services	Finance